Patents by Inventor Masuhiro Yoshitake

Masuhiro Yoshitake has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250041281
    Abstract: A treatment agent for the treatment of curatively unresectable biliary tract cancer that has become refractory or intolerant to cancer chemotherapy and has worsened in a subject is disclosed. The method includes administering a composition to a subject in need of the treatment a composition containing an LAT1 inhibitor, wherein the subject is a LAT1-high expressing patient having Non-Rapid N-acetyltransferase 2.
    Type: Application
    Filed: July 12, 2024
    Publication date: February 6, 2025
    Applicant: J-PHARMA CO., LTD.
    Inventors: Masuhiro YOSHITAKE, Haruki Kusaka
  • Publication number: 20220288035
    Abstract: Provided is a pharmaceutical composition containing O-(5-amino-2-phenylbenzoxazole-7-yl)methyl-3,5-dichloro-L-tyrosine, or a pharmaceutically acceptable salt thereof, for use in treatment of a cancerous disease in a subject, the pharmaceutical composition being administered to the subject having a Non-Rapid (Slow and/or Intermediate) type NAT2 gene.
    Type: Application
    Filed: August 31, 2020
    Publication date: September 15, 2022
    Applicant: J-PHARMA CO., LTD.
    Inventors: Masuhiro YOSHITAKE, Yoshinori BAMBA, Hitoshi ENDOU, Tokiko SUZUKI
  • Publication number: 20220288036
    Abstract: Provided is a pharmaceutical composition including O-(5-amino-2-phenylbenzoxazole-7-yl)methyl-3,5-dichloro-L-tyrosine, or a pharmaceutically acceptable salt thereof, for use in treatment of a disease such as an allergic disease, an autoimmune disease, or an inflammatory disease in a subject, the pharmaceutical composition being administered to the subject having a Non-Rapid (Slow and/or Intermediate) type NAT2 gene.
    Type: Application
    Filed: August 31, 2020
    Publication date: September 15, 2022
    Applicant: J-PHARMA CO., LTD.
    Inventors: Masuhiro YOSHITAKE, Yoshinori BAMBA
  • Publication number: 20100184784
    Abstract: The present invention relates to pharmaceutical compositions comprising at least one multifunctional phosphodiesterase inhibitor (MPDEI) and at least one adenosine uptake inhibitor. The present invention also relates to compositions comprising cilostazol and dipyridamole and their use.
    Type: Application
    Filed: January 8, 2010
    Publication date: July 22, 2010
    Inventors: Yongge LIU, Bing SUN, Masuhiro YOSHITAKE, Jun-ichi KAMBAYASHI
  • Publication number: 20080200484
    Abstract: The present invention relates to pharmaceutical compositions comprising at least one multifunctional phosphodiesterase inhibitor (MPDEI) and at least one adenosine uptake inhibitor. The present invention also relates to compositions comprising cilostazol and dipyridamole and their use.
    Type: Application
    Filed: October 27, 2007
    Publication date: August 21, 2008
    Inventors: Yongge Liu, Bing Sun, Masuhiro Yoshitake, Jun-ichi Kambayashi
  • Publication number: 20050165030
    Abstract: The present invention relates to pharmaceutical compositions comprising at least one multifunctional phosphodiesterase inhibitor (MPDEI) and at least one adenosine uptake inhibitor. The present invention also relates to compositions comprising cilostazol and dipyridamole and their use.
    Type: Application
    Filed: December 26, 2002
    Publication date: July 28, 2005
    Inventors: Yongge Liu, Bing Sun, Masuhiro Yoshitake, Jun-ichi Kambayashi